Tasigna 150 MG Oral Capsule

RxCUI: 1002300
RxNorm name: Tasigna 150 MG Oral Capsule
Display name: Tasigna 150 MG Oral Capsule
Full name: Tasigna 150 MG Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tasigna	NILOTINIB	Novartis Pharmaceuticals Corporation	6093952a-5248-45cb-ad17-33716a411146	2025-12-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1002300

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6093952a-5248-45cb-ad17-33716a411146	Tasigna 150 MG Oral Capsule	SY	42	These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 2007	20251216
6093952a-5248-45cb-ad17-33716a411146	Tasigna (as nilotinib HCl) 150 MG Oral Capsule	SY	42	These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 2007	20251216
6093952a-5248-45cb-ad17-33716a411146	Tasigna 150 MG Oral Capsule	PSN	42	These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 2007	20251216
6093952a-5248-45cb-ad17-33716a411146	nilotinib 150 MG Oral Capsule [Tasigna]	SBD	42	These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 2007	20251216